Cite
HARVARD Citation
Schaefer, G. et al. (n.d.). Preclinical validation of ERK inhibition via GDC-0994 as a potent therapeutic strategy in BRAFV600E mutant colorectal cancers. European journal of cancer. pp. S30-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schaefer, G. et al. (n.d.). Preclinical validation of ERK inhibition via GDC-0994 as a potent therapeutic strategy in BRAFV600E mutant colorectal cancers. European journal of cancer. pp. S30-. [Online].